Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
ArteraAI is a multimodal artificial intelligence biomarker test that can predict therapy benefit and prognosticate long-term outcomes in prostate cancer.
Related Articles
Spironolactone Does Not Lower CV Mortality, HF Hospitalization Risk in Patients on Dialysis – Renal and Urology News
Although spironolactone is very effective in patients that do not require dialysis, investigators tested whether spironolactone is effective in patients on dialysis in a phase…
FDA approves integrated sacral neuromodulation system for urinary urge incontinence
The approval is supported by landmark results from the pivotal phase 2 SANS-UUI trial.
Member Benefits & Programs – American Urological Association
2023 Dues ($USD) $589 * $115 * $349, $314, $278 ◊ $150, $75, $50 ◊ $209 ^ $209 $209 $0 * Dues for Active/Associate members…
The Urology News Imaging Competition 2025
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
Impact of 3D-Printed Models for Surgical Planning in Renal Cell Carcinoma With Venous Tumor Thrombus: A Randomized Multicenter Clinical Trial | Journal of Urology
Purpose:Our goal was to determine whether surgical planning based on 3D models allows for better surgical outcomes than conventional surgical planning in (1) complications, (2)…
Development and Validation of the Length, Segment, and Etiology Anterior Urethral Stricture Disease Staging System Using Longitudinal Urethroplasty Outcomes Data From the Trauma and Urologic Reconstructive Network of Surgeons | Journal of Urology
Purpose:The purpose of this study was to create and validate an anterior urethral stricture disease (aUSD) staging system based on the previously validated Length (L),…
Khurshid Ghani, MBChB, MS, FRCS, on current barriers to stent omission
Khurshid R. Ghani, MBChB, MS, FRCS, discussed how results from the SOUL study may shape clinical decision-making regarding stent placement.
CLINICAL TRIALS A Primer on Clinical Trials for Urologists, Part 2: The FDA – American Urological Association
The FDA was founded in 1906 and is a federal agency of the US Department of Health and Human Services that is responsible for protecting…
Acellular Tissue Engineered Vessel Maintains Hemodialysis Patency Better Than AVF in High-Risk Patients
Investigators successfully tested an acellular tissue engineered vessel for hemodialysis vascular access in patients at high-risk for arteriovenous fistula (AVF) maturation failure.
EAU Guidelines on Urethral Strictures – DISEASE MANAGEMENT IN MALES – Uroweb
The European Association of Urology (EAU) Urethral Strictures Guidelines aim to provide a comprehensive overview of urethral strictures in male, female, and transgender patients.
